Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the RNA Analysis/ Transcriptomics Market’s size between 2026 and 2030?

The rna analysis/ transcriptomics market has experienced substantial growth in recent years. It is projected to expand from $8.74 billion in 2025 to $10.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.9%. The growth observed in the historic period can be attributed to the expansion of genomic research programs, the increasing adoption of rna sequencing technologies, rising funding for life sciences research, the availability of advanced laboratory instruments, and growing academic research activity.

The rna analysis/ transcriptomics market size is anticipated to experience significant expansion over the next few years, with projections indicating it will reach $19.04 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.8%. This projected growth throughout the forecast period is driven by various factors, including the increasing demand for precision medicine applications, the rising utilization of transcriptomics in drug discovery, the broadening of clinical diagnostics based on gene expression, growing investments in bioinformatics infrastructure, and an increasing emphasis on personalized therapeutics. Key trends expected during this period involve the wider adoption of next-generation sequencing platforms, an increase in high-throughput transcriptomic profiling, the growing integration of advanced bioinformatics tools, the expansion of single-cell rna analysis techniques, and an enhanced focus on data accuracy and reproducibility.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5241&type=smp

Which Drivers Are Shaping Strategic Decisions In The RNA Analysis/ Transcriptomics Market?

The increasing occurrence of chronic illnesses is anticipated to drive the expansion of the RNA analysis/ transcriptomics market in the future. These conditions are defined as health issues persisting for at least a year, hindering daily routines, demanding ongoing medical attention, or a combination of these factors. The growing incidence of chronic diseases largely stems from increasingly inactive lifestyles, where reduced daily physical exercise compromises metabolic well-being and heightens the risk of acquiring long-term ailments. RNA analysis/transcriptomics assists in managing chronic diseases by uncovering gene activity shifts that drive the illness, thereby facilitating earlier identification, more precise diagnosis, and the creation of focused, individualized therapies. As an illustration, in June 2024, data from the National Health Service, a UK-based government department, indicated that 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a state characterized by elevated blood sugar levels, not severe enough to be categorized as diabetes) in 2023. This represented an 18% increase from the 3,065,825 cases recorded in 2022. Consequently, the rising occurrence of chronic illnesses is fueling the expansion of the RNA analysis/ transcriptomics market.

What Segment Categories Are Covered In The RNA Analysis/ Transcriptomics Market?

The rna analysis/ transcriptomics market covered in this report is segmented –

1) By Product: Reagents/Consumables, Instruments, Software

2) By Technology, Microarrays, Sequencing, Polymerase Chain Reaction

3) By Application: Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics, RNA Interference

Subsegments:

1) By Reagents/Consumables: Nucleotides, Enzymes, Buffers and Solutions, Sample Preparation Kits, Sequencing Kits

2) By Instruments: Sequencers, Real-Time PCR Machines, Microarrays, Electrophoresis Systems, Robotic Liquid Handlers

3) By Software: Data Analysis Software, Bioinformatics Tools, Statistical Analysis Software, Visualization Software, Database Management Systems

What Trends Are Projected To Support The Growth Of The RNA Analysis/ Transcriptomics Market?

Leading companies in the RNA analysis/ transcriptomics market are intensifying their efforts to introduce innovative product portfolios to gain a competitive edge. These RNA portfolios involve the development of new technologies and solutions designed to enhance the efficiency and effectiveness of RNA analysis. For instance, in May 2023, Twist Bioscience Corporation, a US-based biotechnology company, announced the introduction of a suite of RNA sequencing tools. This suite includes specific target enrichment capabilities for RNA and whole transcriptome sequencing, alongside the Twist RNA Exome, Twist RNA Library Prep Kit, and the Twist Ribosomal RNA (rRNA) and Hemoglobin (Globin) Depletion Kit. The portfolio delivers comprehensive workflows for analyzing messenger RNA (mRNA) protein coding sequences, custom targets, and total RNA, with the aim of measuring the transcriptome. Moreover, these offerings can be integrated into clients’ existing workflows.

Which Key Market Players Are Investing In Expansion And Innovation Within The RNA Analysis/ Transcriptomics Market?

Major companies operating in the rna analysis/ transcriptomics market are Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., Fluidigm Corporation, Promega Corporation, bioMérieux S.A., CD Genomics Inc., Eurofins Scientific SE, Merck KGaA, Pacific Biosciences of California Inc., Danaher Corporation, Genewiz Inc., Oxford Nanopore Technologies Ltd., BGI Group, Genotypic Technology Pvt. Ltd., MedGenome Labs Pvt. Ltd., Xcelris Labs Ltd., Ocimum Biosolutions Ltd., Strand Life Sciences Pvt. Ltd., SciGenom Labs Pvt. Ltd., Oncocyte Corporation, Tempus Labs Inc., ArcherDX Inc., HTG Molecular Diagnostics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The RNA Analysis/ Transcriptomics Market?

North America was the largest region in the RNA analysis/transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rna analysis/ transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized RNA Analysis/ Transcriptomics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=5241&type=smp

Browse Through More Reports Similar to the Global RNA Analysis/ Transcriptomics Market 2026, By The Business Research Company

Rna Sequencing Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Ngs Based Rna Sequencing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Ribonucleic Acid Rna Sequencing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company